Mikael Dolsten compensation by year
PFIZER Summary Compensation Table · all 9 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|
| Salary | $1,237,500 | $1,271,250 | $1,306,250 | $1,400,000 | $1,433,750 | $1,478,750 | $1,535,000 | $1,596,500 | $1,654,300 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $1,144,494 | $1,882,190 | $2,013,091 | $2,414,725 | $2,110,585 | $2,531,393 | $3,471,267 | $3,115,268 | $1,565,751 |
| Option awards | $1,835,559 | $1,801,215 | $2,108,995 | $2,531,376 | $2,608,832 | $3,021,712 | $2,931,212 | $2,920,565 | $3,318,434 |
| Non-equity incentive | $1,740,000 | $1,150,000 | $1,326,000 | $1,820,000 | $2,600,000 | $3,250,000 | $3,530,972 | $0 | $2,895,200 |
| Pension and deferred compensation | $1,043,662 | $1,332,809 | $0 | $987,243 | $928,638 | $0 | $0 | $413,970 | $0 |
| All other | $1,226,758 | $233,351 | $315,863 | $444,701 | $467,819 | $633,135 | $749,782 | $812,397 | $309,604 |
| Total | $8,227,973 | $7,670,815 | $7,070,199 | $9,598,045 | $10,149,624 | $10,914,990 | $12,218,233 | $8,858,700 | $9,743,289 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PFIZER INC DEF 14A filed March 13, 2025, accession 0000078003-25-000062, and prior-year filings. Open the filing on EDGAR.
How this page was built: the PFIZER INC filed document, accession 0000078003-25-000062. Every figure is read from that document and cited to the page and table it appears in. Filed March 13, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 111,566 | $2,959,846 | — |
| PSU | 70,258 | $1,863,945 | — |
| PSU | 63,118 | $1,674,521 | — |
| PSU | 56,553 | $1,500,348 | — |
| PSU | 31,275 | $829,722 | — |
| Option | 137,760 | — | $42.30 |
| Option | 210,697 | — | $33.82 |
| Option | 111,516 | — | $45.96 |
| Option | 126,794 | — | $45.96 |
| Option | 182,050 | — | $33.82 |
| Option | 214,880 | — | $26.89 |
| Option | 119,894 | — | $42.30 |
Per the Outstanding Equity Awards at Fiscal Year-End table in PFIZER INC's FY2024 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 15 award rows shown.
PFIZER’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Albert Bourla | Chairman and Chief Executive Officer | $24,648,727 |
| Mikael Dolsten · this page | Chief Scientific Officer, President, Pfizer Research & Development | $9,743,289 |
| Aamir Malik | Chief U.S. Commercial Officer, Executive Vice President | $8,294,270 |
| David Denton | Chief Financial Officer, Executive Vice President | $8,124,542 |
| Chris Boshoff | Chief Scientific Officer and President, Research & Development | $7,853,984 |
| Douglas Lankler | Chief Legal Officer, Executive Vice President | $6,814,115 |
The full PFIZER compensation record
free company briefThis page is one person within PFIZER's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the PFIZER proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PFIZER's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.